NFA
NERV icon

Nationwide Fund Advisors’s Minerva Neurosciences NERV Stock Holding History

Nationwide Fund Advisors’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-15,624
Closed -$950K – 1352
2017
Q3 		$950K Buy
15,624
+13,998
+861% +$803K ﹤0.01% 1825
2017
Q2 		$115K Buy
1,626
+202
+14% +$13.1K ﹤0.01% 2846
2017
Q1 		$92K Hold
1,424
– – ﹤0.01% 2867
2016
Q4 		$134K Sell
1,424
-6
-0.4% -$612 ﹤0.01% 2777
2016
Q3 		$162K Buy
1,430
+133
+10% +$12.9K ﹤0.01% 2725
2016
Q2 		$106K Buy
+1,297
New +$82.5K ﹤0.01% 2887

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Nationwide Fund Advisors's NERV Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Minerva Neurosciences (NERV) in Q4 2017, closing a stake of 15,624 shares — an estimated $950K sold.

Nationwide Fund Advisors first reported a position in NERV in Q2 2016 and held it in 6 quarters. The position peaked at $950K in Q3 2017. 67 funds tracked by Wall St. Rank hold NERV as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Minerva Neurosciences position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 15,624 Minerva Neurosciences shares in Q4 2017, an estimated $950K.
  • Nationwide Fund Advisors first reported a position in Minerva Neurosciences in Q2 2016 and held it in 6 quarters.
  • Nationwide Fund Advisors's Minerva Neurosciences position peaked at $950K in Q3 2017.
  • 67 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.